OCT 09, 2018 3:19 PM PDT

Weight Loss Drug Reduces Incidence of Diabetes

WRITTEN BY: Nouran Amin

Image via The San Diego Tribune

A clinical trial weight loss drug, by the name of Lorcaserin—manufactured by Eisai Inc., was found to reduce the risk of diabetes by 19 percent in patients with pre-diabetes as well as reducing the risk of diabetic microvascular complications such as microalbuminuria. "We recently presented findings showing that use of lorcaserin resulted in modest but sustained weight loss among obese and overweight patients without increasing risk of heart attack and stroke," said co-lead author Erin Bohula, MD, DPhil, a BWH cardiovascular medicine specialist. "Now we report that, when added to lifestyle interventions, lorcaserin significantly reduced incidence of diabetes, increased rates of diabetes remission, and reduced the risk of diabetic microvascular complications."

The findings of the study were recently published in The Lancet.

"Taken together, these findings reinforce the notion that modest, durable weight loss can improve cardiometabolic health and supports the role of lorcaserin as an adjunctive therapy in chronic weight management," explains co-lead author Benjamin Scirica, MD, also a fellow cardiovascular medicine specialist at BWH and senior investigator for the TIMI Study Group. "It provides another tool in the armamentarium, beyond diet and exercise, for patients hoping to achieve and maintain weight loss. And, happily, as we saw, even relatively modest weight loss can improve the diabetes control in those with diabetes and reduce the development of diabetes in those at risk."

In addition to reducing the risk of diabetes and diabetic microvascular complications (e.g. persistent microalbuminuria, diabetic retinopathy or diabetic neuropathy), as well as decreasing weight, Lorcaserin was found to increase the remission rate to the rate of hyperglycemia in patients with diabetes. Additionally, despite patients having well-controlled diabetes at the start of the clinical studies, lorcaserin resulted in a reduction of hemoglobin A1c levels (a measure of glucose control).

However, there were side effects of lorcaserin with 6.6 percent of the patients reporting dangerously low levels of blood sugar known as Hypoglycemia. Cases of severe hypoglycemia requiring hospitalization were especially prevalent among patients taking medications known to have hypoglycemic effects such as insulin or sulfonylurea’s, medications known to result in hypoglycemia.

 

 

Such findings has encouraged researchers to highlight the importance of carefully titrating agents associated with the risk hypoglycemic events, especially if patients are on weight loss.

"Given the global prevalence of obesity and its association with type 2 diabetes and complications that can cause death or greatly diminish quality of life, we need therapeutic strategies that can be added to lifestyle modification to prevent and control diabetes," said Scirica. "This rigorous and large-scale randomized study demonstrates the potential for improving glycemic control when adding a weight loss agent to a treatment plan."

Source: Brigham and Women’s Hospital

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 22, 2019
Health & Medicine
NOV 22, 2019
Federal Government Weighs in on Marijuana and Opioid Addiction
The U.S. government is weighing in on the hot topic of whether or not medical marijuana is a successful tool in treating opioid addiction by barring the us...
DEC 08, 2019
Drug Discovery & Development
DEC 08, 2019
Parkinson's Drug Reduces Hallucinations in Dementia Patients
Pimavanserin, also known as Nuplazid, was approved in the US to treat Parkinson’s-related psychosis in 2016. Now, new research has shown that it also...
DEC 22, 2019
Genetics & Genomics
DEC 22, 2019
New Gene Therapy Uses Exosomes to Reverse Disease
Researchers at Ohio State University have developed a new gene therapy that makes use of exosomes, fluid sacs released in cells, to carry therapeutic tools...
JAN 03, 2020
Drug Discovery & Development
JAN 03, 2020
Researchers Grow Psilocybin from E. Coli Bacteria
Previously considered to be narcotic, and under tight regulation as an illicit drug for decades, research from recent years on the possible medicinal prope...
JAN 14, 2020
Cancer
JAN 14, 2020
Could the flu vaccine shrink cancer tumors?
If you’ve been to the doctor recently, you’ve probably been asked if you want a flu shot this year. The flu vaccine is popular because it reduc...
FEB 21, 2020
Health & Medicine
FEB 21, 2020
Frequent Cannabis Use Could Affect Driving Safety
A new study suggests that heavy marijuana users have the potential to be dangerous drivers. However, hazardous driving appears to be isolated to users who ...
Loading Comments...